POSTPONED UNTIL FURTHER NOTICE

Physicians need the most up-to-date knowledge and strategies in clinical pathology to provide the most appropriate ancillary testing and patient care. In order to address this need, this activity will provide the following:

• Define risk stratification based on cytology and HPV testing in gynecologic cytology
• Discuss urinary cytology reporting terminology and risk of malignancy associated with each
• Understand the role of HPV testing in oropharyngeal cancers
• Apply appropriate molecular testing of small specimens for management of lung cancers
• Describe the diagnosis, molecular testing and management of thyroid nodules and update to Thyroid Bethesda System Reporting
• Discuss how the risk of malignancy in reporting terminology is affected by inclusion of noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP)

Physicians, residents and fellows, pathologists, cytopathologists, cytotechnologists, residents and fellows in pathology, ENT, endocrinology, urology, and internal medicine will benefit from this course.

Course Directors:

Dina R. Mody, MD 
Professor of Pathology and Genomic Medicine, Institute for Academic Medicine
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College
 

Mary R. Schwartz, MD
Medical Director, Anatomic Pathology Director 
Pathology - Anatomic & Clinical Pathology - Cytopathology

events.houstonmethodist.org/cytopathology-update